Enclosed please find herewith intimation with respect to allotment of Equity Shares under the "Employee Stock Option Scheme, 2021".
ALIVUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Alivus Life Sciences (formerly Glenmark Life Sciences) has allotted 3,100 equity shares of Rs. 2 each to eligible employees who exercised stock options under the ESOS 2021 scheme. The Board approved this at its meeting on May 14, 2026. Following the allotment, the company's paid-up share capital increased marginally from Rs. 24,54,72,696 to Rs. 24,54,78,896, reflecting the issuance of a very small number of shares relative to the total capital base of over 12.27 crore shares.
The dilution from 3,100 new shares is negligible — less than 0.003% of total shares outstanding — and is unlikely to have any material impact on the stock price or shareholder value.